# Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT

> **NCT02963129** · PHASE3 · UNKNOWN · sponsor: **Hospital Italiano de Buenos Aires** · enrollment: 40 (estimated)

## Conditions studied

- Hereditary Hemorrhagic Telangiectasia
- Epistaxis

## Interventions

- **DRUG:** Mupirocin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02963129
- **Lead sponsor:** Hospital Italiano de Buenos Aires
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02963129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02963129, "Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02963129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*